Vilon is a remarkable molecule — a simple dipeptide consisting of just two amino acids, lysine and glutamic acid (Lys-Glu), discovered through decades of research at the St Petersburg Institute of Bioregulation. Despite its tiny size, Vilon demonstrates measurable bioactivity at very low concentrations, making it one of the most efficient signalling molecules ever characterised.
Pan-Vilon is the commercial bioregulator formulation containing Vilon. The peptide has been studied for its effects on lymphocyte function, telomerase activity in cell culture, and longevity-relevant gene expression. Animal studies have suggested life-extension effects under controlled experimental conditions.
The mechanism is consistent with Khavinson's broader bioregulator hypothesis: short peptides enter cells, bind directly to specific gene promoter regions, and modulate physiological protein synthesis in tissue-matched cells. The remarkable feature of Vilon is that this activity occurs with just two amino acids — proof that bioactivity does not require large molecular complexity.
Pan-Vilon is typically used in 30-day cycles, repeated 2–3 times per year. It pairs well with longevity-focused bioregulators like Endoluten (pineal peptide) and Vladonix (thymus peptide) within an integrative healthy-aging protocol.
Pan-Vilon is well tolerated with no significant interactions reported in the bioregulator literature. As with all peptide bioregulators, those with active autoimmune disease or on immunosuppressive therapy should consult their physician before use.
